Clinical Trial Update: A Comparison of Eleview Versus Hetastarch as Injectate for EMR [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Eleview to Hetastarch as an injectate for endoscopic mucosal resection to address procedural bleeding outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post Procedural Complication
• Post-polypectomy Syndrome
• Procedural Bleeding

Drugs mentioned

• Eleview (elevis)
• Hetastarch (hetastarch)

Snippet

Sponsor: Indiana University | Conditions: Procedural Bleeding, Delayed Bleeding | Phase 4 | Status: COMPLETED | Results posted: 2019-12-17